If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Marketing Management » Patient Advocacy
Download FREE Excerpt
15 Info Graphics
15 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Patients with chronic conditions like rheumatoid arthritis and osteoporosis are frequent users of the healthcare system. Thus it is vital for this patient group to understand how to navigate the managed care labyrinth. To help patients understand how the reimbursement system works and effective ways to navigate it, leading pharmaceutical organizations use brand websites to facilitate online patient support for reimbursement and access issues. Additionally, some patient groups need treatment training or guidance for conditions involving the use of injections at home.
Best Practices, LLC conducted this study to showcase different online approaches and tools that leading organizations utilize to provide online patient support for insurance issues. Additionally, the study reveals multiple online training tutorials used by benchmark brands in helping patients regarding administration of injections and medicines at home.
The benchmark framework probed 10 chronic care product websites to glean online approaches and tools for patient support regarding reimbursement and access issues. Additionally, online tools and approaches were reviewed for helping train patients who require injection treatments. Benchmark products examined include: Boniva, Cimzia, Enbrel, Forteo, Fosamax, Humira, Reclast, Remicade, Rituxan, and Simponi.
Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Medical Device
Abbott; Amgen; Centocor Ortho Biotech Inc.; Eli Lilly; Genentech; Johnson & Johnson; Merck; Novartis; Roche; UCB Pharma